Specialist/Principal Scientist - Vascular Biology
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Måløv
Are you passionate about research and would you like to be part of a dynamic and dedicated team striving to change the quality of life for millions of people living with chronic diseases? If yes, then apply today and join Type 2 Diabetes and Cardiovascular Disease Research here at Novo Nordisk.
The position
As a Specialist/Principal Scientist, you will be part of project groups identifying new treatment options for cardiovascular and other cardiometabolic diseases. The job encompasses active engagement in innovation and in understanding the mode of action supporting the characterization of novel treatments. One of the key role responsibilities will be project execution with a focus on the design of in vitro experiments to validate human relevance; utilization of translational tools and exploration of the mechanism of action. You will work closely with other team members to move projects forward across the value chain. Furthermore, you will take part in evaluating potential external opportunities from academia, biotech, or pharma.
Qualifications
You hold a PhD within Life Sciences with around 5 years of research experience related to cardiovascular physiology.
To succeed in this role, you are expected to have: Drug discovery experience from pharmaceutical industry Profound experience with setting up and running advanced human in vitro models of vascular diseases A scientific track-record within vascular pathophysiology International experience and a strong network within esteemed academic institutions Proficiency in both spoken and written English On a personal level, you are dedicated, pro-active, well-organized, and responsible and have a passion for troubleshooting and experimentation. In addition, you are collaborative and a team player and can operate in a dynamic environment with multiple concurrent tasks.
About the department
The position is anchored in the Vascular Biology department that is part of Type 2 Diabetes and Cardiovascular Disease Research within Global Drug Discovery, Novo Nordisk A/S. As part of Novo Nordisk’s strategy within chronic metabolic diseases, we are focusing on target identification, target validation, and pre-clinical characterization of new assets intended to become novel treatment options for patients living with cardiometabolic diseases. In close collaboration with our colleagues, we are working in an organ-centric and disease agnostic manner to develop, characterize, and utilize in vitro tools to elucidate mode-of-action and profiling of novel biology and molecules for early evaluation of drug candidates.
Working at Novo Nordisk
We are a proud life-science company, and life is our reason to exist. We’re inspired by life in all its forms and shapes, ups and downs, opportunities and challenges. For employees at Novo Nordisk, life means many things – from the building blocks of life that form the basis of ground-breaking scientific research, to our rich personal lives that motivate and energise us to perform our best at work. Ultimately, life is why we’re all here - to ensure that people can lead a life independent of chronic disease. Contact
For more information, please contact Michael Nyberg, Director, Vascular Biology at [email protected]. Deadline
15 October 2023.
Applications will be reviewed on an ongoing basis and position will be closed when we find the right candidate.
You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
The position
As a Specialist/Principal Scientist, you will be part of project groups identifying new treatment options for cardiovascular and other cardiometabolic diseases. The job encompasses active engagement in innovation and in understanding the mode of action supporting the characterization of novel treatments. One of the key role responsibilities will be project execution with a focus on the design of in vitro experiments to validate human relevance; utilization of translational tools and exploration of the mechanism of action. You will work closely with other team members to move projects forward across the value chain. Furthermore, you will take part in evaluating potential external opportunities from academia, biotech, or pharma.
Qualifications
You hold a PhD within Life Sciences with around 5 years of research experience related to cardiovascular physiology.
To succeed in this role, you are expected to have:
About the department
The position is anchored in the Vascular Biology department that is part of Type 2 Diabetes and Cardiovascular Disease Research within Global Drug Discovery, Novo Nordisk A/S. As part of Novo Nordisk’s strategy within chronic metabolic diseases, we are focusing on target identification, target validation, and pre-clinical characterization of new assets intended to become novel treatment options for patients living with cardiometabolic diseases. In close collaboration with our colleagues, we are working in an organ-centric and disease agnostic manner to develop, characterize, and utilize in vitro tools to elucidate mode-of-action and profiling of novel biology and molecules for early evaluation of drug candidates.
Working at Novo Nordisk
We are a proud life-science company, and life is our reason to exist. We’re inspired by life in all its forms and shapes, ups and downs, opportunities and challenges. For employees at Novo Nordisk, life means many things – from the building blocks of life that form the basis of ground-breaking scientific research, to our rich personal lives that motivate and energise us to perform our best at work. Ultimately, life is why we’re all here - to ensure that people can lead a life independent of chronic disease. Contact
For more information, please contact Michael Nyberg, Director, Vascular Biology at [email protected]. Deadline
15 October 2023.
Applications will be reviewed on an ongoing basis and position will be closed when we find the right candidate.
You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your resume or CV. To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".
Arbejdsstedet er beliggende i Måløv.
Jobbet er oprettet på vores service den 29.8.2023, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Forretningsudvikler
- Måløv
Lignende jobs
-
Strategic Trial Planning Manager - Clinical Develo...
Are you ready to drive the successful strategic planning and management of early phase clinical trials, i.e. ClinPharm/Phase 1 studies? Does oversight and cross functional collaboration motivate yo..Få mere info- Forretningsudvikler
- Søborg
-
Senior Scientist in Late-stage Downstream Developm...
Are you ready to shape the future of API process characterization in late-stage downstream development? Do you have the expertise to drive innovative solutions and ensure seamless tech transfer in .Få mere info- Forretningsudvikler
- Bagsværd
-
Global Trial Manager
Are you passionate about clinical development? Is ensuring that clinical trials produce high-quality data and scientific documentation your top priority? If so, we want you to join our team in Card..Få mere info- Forretningsudvikler
- Søborg
-
Udviklingskonsulent til det sociale børne- og unge...
Få mere info- Forretningsudvikler
- Taastrup
Statistik over udbudte jobs som forretningsudviklere i Måløv
Herunder ser du udviklingen i udbudte forretningsudvikler i Måløv over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.
Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Måløv over tid
| Dato | Alle jobs som forretningsudviklere |
|---|---|
| 23. november 2024 | 3 |
| 22. november 2024 | 3 |
| 21. november 2024 | 3 |
| 20. november 2024 | 4 |
| 19. november 2024 | 3 |
| 18. november 2024 | 3 |
| 17. november 2024 | 5 |
| 16. november 2024 | 5 |
| 15. november 2024 | 5 |
| 14. november 2024 | 5 |
| 13. november 2024 | 5 |
| 12. november 2024 | 5 |
| 11. november 2024 | 4 |
| 10. november 2024 | 4 |
| 9. november 2024 | 4 |
| 8. november 2024 | 3 |
| 7. november 2024 | 2 |
| 6. november 2024 | 1 |
| 5. november 2024 | 1 |
| 4. november 2024 | 1 |
| 3. november 2024 | 3 |
| 2. november 2024 | 3 |
| 1. november 2024 | 3 |
| 31. oktober 2024 | 4 |
| 30. oktober 2024 | 4 |
| 29. oktober 2024 | 4 |
| 28. oktober 2024 | 4 |
| 27. oktober 2024 | 6 |
| 26. oktober 2024 | 6 |
| 25. oktober 2024 | 7 |
| 24. oktober 2024 | 7 |